Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | December 31, 2010 | February 11, 2011 |
| EQUITY LIFESTYLE PROPERTIES INCELS · Entity 3434 | Director | April 01, 2024 | April 03, 2024 |
| Rush Street Interactive, Inc.RSI · Entity 2291 | Director | June 10, 2021 | June 11, 2021 |
| SPIRIT REALTY CAPITAL, INC.SRC · Entity 94984 | Director | June 08, 2020 | June 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date December 31, 2010 · Filed February 11, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 127,045.9503 |
Reported balance
Holding disclosure · report date 2010-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 127,045.9503 F1: The purpose to this Form 5 is to correct the share balance in connection with dividend reinvestment shares not previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: The purpose to this Form 5 is to correct the share balance in connection with dividend reinvestment shares not previously reported.
EQUITY LIFESTYLE PROPERTIES INC
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.01SEC Table I · non-derivative | Direct | 743,668 |
Reported balance
After 2024-04-01 transaction · row 1
1 source rowRow 1 · 2024-04-01 · Grant · Acquired 229 · Balance 743,668 F1: Represents shares acquired through ELS' Employee Stock Purchase Plan |
| Common Stock, par value $.01SEC Table I · non-derivative | IndirectBy Spouse | 378,255.28 |
Reported balance
Holding disclosure · report date 2024-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 378,255.28 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares acquired through ELS' Employee Stock Purchase Plan
Rush Street Interactive, Inc.
Report date June 10, 2021 · Filed June 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,710 |
Reported balance
After 2021-06-10 transaction · row 1
1 source rowRow 1 · 2021-06-10 · Grant · Acquired 9,085 · Balance 17,710 F1: On June 10, 2021, the Reporting Person was awarded 9,085 restricted stock units (the "RSUs") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2021, the Reporting Person was awarded 9,085 restricted stock units (the "RSUs") under the Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan. The RSUs vest as of the Issuer's next annual meeting of stockholders to be held in calendar year 2022.
SPIRIT REALTY CAPITAL, INC.
Report date June 08, 2020 · Filed June 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.05 per shareSEC Table I · non-derivative | Direct | 18,294 |
Reported balance
After 2020-06-08 transaction · row 1
1 source rowRow 1 · 2020-06-08 · Grant · Acquired 2,754 · Balance 18,294 F1: 2020 Annual Restricted Stock Award for Director service. Restrictions lapse 12 months following the date of grant subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: 2020 Annual Restricted Stock Award for Director service. Restrictions lapse 12 months following the date of grant subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2006 Filed May 15, 2006 22:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 4,540 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198219-06-000009 · doc.xml · derivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,474 Underlying: Common Stock · 4,540 shares Expires not disclosed F3 · kind: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F4 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F4 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 11, 2006 Filed May 15, 2006 22:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 872 | $30.07 | $26,221.04 |
DisclosureSEC source: 0001198219-06-000009 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,011 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 21, 2006 Filed Mar 23, 2006 19:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 33 | $29.71 | $980.43 |
DisclosureSEC source: 0001198220-06-000014 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,139 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 09, 2006 Filed Mar 13, 2006 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 32 | $30.47 | $974.88 |
DisclosureSEC source: 0001009124-06-000011 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,106 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| March 01, 2006 Filed Mar 2, 2006 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 104 | $28.82 | $2,996.76 |
DisclosureSEC source: 0001198220-06-000007 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,074 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| February 28, 2006 Filed Mar 2, 2006 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 35 | $28.55 | $999.08 |
DisclosureSEC source: 0001198220-06-000007 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,970 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| February 16, 2006 Filed Feb 17, 2006 21:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 68 | $29.04 | $1,974.72 |
DisclosureSEC source: 0001009124-06-000007 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,935 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 22, 2005 Filed Dec 22, 2005 21:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 36 | $27.43 | $987.30 |
DisclosureSEC source: 0001198222-05-000020 · doc.xml · nonDerivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,867 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 21, 2005 Filed Dec 22, 2005 21:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 36 | $27.71 | $997.38 |
DisclosureSEC source: 0001198222-05-000020 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,831 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 16, 2005 Filed Dec 19, 2005 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 35 | $28.56 | $999.43 |
DisclosureSEC source: 0001198220-05-000047 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,570 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 22, 2005 Filed Nov 23, 2005 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 36 | $27.36 | $984.78 |
DisclosureSEC source: 0001198219-05-000012 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,535 F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 02, 2005 Filed Nov 3, 2005 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,033 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-05-000015 · doc.xml · derivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,881 Underlying: Common Stock · 1,033 shares Expires not disclosed F3 · kind: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F4 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F4 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 02, 2005 Filed Nov 3, 2005 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 123 | $24.20 | $2,975.99 |
DisclosureSEC source: 0001174477-05-000015 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,499 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| October 07, 2005 Filed Oct 11, 2005 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 38 | $25.96 | $986.29 |
DisclosureSEC source: 0001198220-05-000040 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,376 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 14, 2005 Filed Sep 16, 2005 16:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 102 | $29.39 | $2,997.78 |
DisclosureSEC source: 0001198220-05-000027 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,338 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| July 29, 2005 Filed Aug 2, 2005 19:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 32 | $31.11 | $995.36 |
DisclosureSEC source: 0001198220-05-000024 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| July 06, 2005 Filed Jul 8, 2005 16:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 34 | $29.64 | $1,007.59 |
DisclosureSEC source: 0001198220-05-000021 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,204 F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 12, 2005 Filed May 16, 2005 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 613 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-05-000007 · c0001198222d20050516f4f.xml · derivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,902 Underlying: Common Stock · 613 shares Expires not disclosed F3 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F4 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F4 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 12, 2005 Filed May 16, 2005 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,000 | $53.83 | $107,650.00 |
DisclosureSEC source: 0001174477-05-000007 · c0001198222d20050516f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,085 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 02, 2005 Filed May 4, 2005 20:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 19 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198222-05-000007 · c0001198222d20050504f4f.xml · derivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,289 Underlying: Common Stock · 19 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| March 21, 2005 Filed Mar 22, 2005 21:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 19 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001194405-05-000011 · c0001198222d20050322f4f.xml · derivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,270 Underlying: Common Stock · 19 shares Expires not disclosed F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| March 02, 2005 Filed Mar 4, 2005 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 79 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198220-05-000008 · c0001198222d20050304f4f.xml · derivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,251 Underlying: Common Stock · 79 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| February 15, 2005 Filed Feb 17, 2005 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 40 | $48.56 | $1,942.40 |
DisclosureSEC source: 0001198220-05-000004 · c0001198222d20050217f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,085 F1 · kind: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 05, 2005 Filed Jan 6, 2005 22:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 89 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001009124-05-000002 · c0001198222d20050106f4f.xml · derivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,140 Underlying: Common Stock · 89 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| January 04, 2005 Filed Jan 6, 2005 22:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 45 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001009124-05-000002 · c0001198222d20050106f4f.xml · derivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,051 Underlying: Common Stock · 45 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 03, 2004 Filed Nov 5, 2004 17:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 68 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-04-000015 · c0001198222d20041105f4f.xml · derivative · entry 3 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,006 Underlying: Common Stock · 632 shares Expires not disclosed F3 · kind: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F4 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F4 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 03, 2004 Filed Nov 5, 2004 17:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001174477-04-000015 · c0001198222d20041105f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,888 F1 · kind: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 14, 2004 Filed Sep 15, 2004 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 49 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198220-04-000007 · c0001198222d20040915f4f.xml · derivative · entry 3 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,938 Underlying: Common Stock · 49 shares Expires not disclosed F1 · kind: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| September 13, 2004 Filed Sep 15, 2004 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 25 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198220-04-000007 · c0001198222d20040915f4f.xml · derivative · entry 2 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,889 Underlying: Common Stock · 25 shares Expires not disclosed F1 · kind: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| August 05, 2004 Filed Aug 6, 2004 18:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001198220-04-000004 · c0001198222d20040806f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,324 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1996 Directors Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| July 07, 2004 Filed Jul 9, 2004 19:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $42.12 | $968.76 |
DisclosureSEC source: 0001198222-04-000014 · c0001198222d20040709f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,300 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1996 Directors Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 12, 2004 Filed May 14, 2004 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 50 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-04-000008 · c0001198222d20040514f4f.xml · derivative · entry 3 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 Underlying: Common Stock · 50 shares Expires not disclosed F3 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F4 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F4 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 12, 2004 Filed May 14, 2004 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,703 | $39.75 | $107,444.25 |
DisclosureSEC source: 0001174477-04-000008 · c0001198222d20040514f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,277 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1996 Directors Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 05, 2003 Filed Nov 7, 2003 14:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 283 | $35.23 | $9,970.09 |
DisclosureSEC source: 0001174477-03-000039 · c0001198222d20031107f4f.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,403 F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.